JP Morgan Chase
GMAB icon

JP Morgan Chase’s Genmab GMAB Stock Holding History

JP Morgan Chase’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80,000
Closed -$2.63M – 6435
2021
Q1 		$2.63M Buy
+80,000
New +$3.01M ﹤0.01% 3494
2020
Q3 		– Sell
-37,500
Closed -$1.27M – 5576
2020
Q2 		$1.27M Buy
+37,500
New +$1.02M ﹤0.01% 3380

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase's GMAB Position: Q1 2026 in Review

JP Morgan Chase reduced its Genmab (GMAB) stake by 2.6% in Q1 2026, selling an estimated $176K and leaving 222,607 shares worth $5.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

JP Morgan Chase first reported a position in GMAB in Q3 2019 and has held it in 27 quarters since. The position peaked at $19.3M in Q2 2025. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • JP Morgan Chase held 222,607 shares of Genmab worth $5.75M as of Q1 2026.
  • JP Morgan Chase sold 5,881 Genmab shares in Q1 2026, an estimated $176K.
  • Genmab made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3197 holding.
  • JP Morgan Chase first reported a position in Genmab in Q3 2019 and has held it in 27 quarters since.
  • JP Morgan Chase's Genmab position peaked at $19.3M in Q2 2025.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.